The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu) – is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective of the LIT is to develop innovative and efficient cellular immune therapeutics in these areas. Our own GMP laboratories and close networking with University and University Hospital offer excellent opportunities for clinical translation of novel immune cell products.
The Group “Epigenetic Immunooncology” at the LIT is recruiting a
in part-time position (20 hours per week), starting as soon as possible. This position is initially limited to two years, with the possibility of extension.
The Schmidl lab works at the interface of immunology and cancer, which is one of the most exciting fields of recent biomedical research. We provide a dynamic and motivating working environment with flat hierarchies where you can foster your skills and get the opportunity to use top-notch technologies. The small lab size offers excellent mentoring and training opportunities.
Your Tasks
Our Requirements
We offer:
Remuneration is in accordance with TV-L.
The LIT places particular emphasis on promoting a healthy work-life balance.
Applicants with severe disabilities (m/f/d) will be given preference in the event of essentially equal suitability. Please indicate any disability in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Dr. Christian Schmidl (christian.schmidl@ukr.de).
We are looking forward to receiving your detailed application. Please apply via our Online - Application Portal quoting the reference CS-2025-01.
Application deadline is June 22nd, 2025.